Bright Uro launched Thursday with $4 million in seed financing and a $2 million Phase II SBIR grant from the National Institutes of Health. The company has obtained exclusivity to the wireless, catheter-free Glean urodynamics system, which is designed for quantitative urological testing, through a licensing agreement with Cleveland Clinic. Read More